Phase II Study Evaluating the Efficacy of Aflibercept for the Treatment of Choroidal Neovascularization in Angioid Streaks in Young Patients (ASTRID).

NCT02573038 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Choroidal Neovascularization in Angioid Streaks

Interventions

DRUG: Aflibercept

Sponsor

Hospices Civils de Lyon